181 related articles for article (PubMed ID: 10571438)
21. Tetravalent rotavirus vaccine.
Wandstrat TL; Kaplan-Machlis B; Temple ME; Nahata MC
Ann Pharmacother; 1999; 33(7-8):833-9. PubMed ID: 10466913
[TBL] [Abstract][Full Text] [Related]
22. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
23. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR
Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523
[TBL] [Abstract][Full Text] [Related]
24. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Kulkarni PS; Desai S; Tewari T; Kawade A; Goyal N; Garg BS; Kumar D; Kanungo S; Kamat V; Kang G; Bavdekar A; Babji S; Juvekar S; Manna B; Dutta S; Angurana R; Dewan D; Dharmadhikari A; Zade JK; Dhere RM; Fix A; Power M; Uprety V; Parulekar V; Cho I; Chandola TR; Kedia VK; Raut A; Flores J;
Vaccine; 2017 Oct; 35(45):6228-6237. PubMed ID: 28967523
[TBL] [Abstract][Full Text] [Related]
25. Tetravalent rhesus-human rotavirus vaccine (RRV-TV) in Belém, Brazil: efficacy against prevailing P and G genotypes.
Mascarenhas JD; Leite JP; Gabbay YB; Almeida ML; Linhares AC
J Trop Pediatr; 2002 Oct; 48(5):300-2. PubMed ID: 12405173
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period.
Armah GE; Kapikian AZ; Vesikari T; Cunliffe N; Jacobson RM; Burlington DB; Ruiz LP
J Infect Dis; 2013 Aug; 208(3):423-31. PubMed ID: 23599316
[TBL] [Abstract][Full Text] [Related]
27. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine.
Takala AK; Koskenniemi E; Joensuu J; Mäkelä M; Vesikari T
Clin Infect Dis; 1998 Aug; 27(2):272-82. PubMed ID: 9709876
[TBL] [Abstract][Full Text] [Related]
28. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
Lanata CF; Black RE; del Aguila R; Gil A; Verastegui H; Gerna G; Flores J; Kapikian AZ; Andre FE
J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789
[TBL] [Abstract][Full Text] [Related]
29. Rotavirus vaccines: development and use for the prevention of diarrhoeal disease.
Vesikari T
Ann Med; 1999 Feb; 31(1):79-85. PubMed ID: 10219717
[TBL] [Abstract][Full Text] [Related]
30. Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine.
Clemens J; Keckich N; Naficy A; Glass R; Rao M
Epidemiol Rev; 1999; 21(1):24-42. PubMed ID: 10520471
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
32. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
[TBL] [Abstract][Full Text] [Related]
34. [Rotavirus infection in Brazil: epidemiology and challenges for its control].
Linhares AC
Cad Saude Publica; 2000; 16(3):629-46. PubMed ID: 11035503
[TBL] [Abstract][Full Text] [Related]
35. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.
Ward RL; Bernstein DI
Vaccine; 1995 Sep; 13(13):1226-32. PubMed ID: 8578808
[TBL] [Abstract][Full Text] [Related]
36. Rotavirus.
Parashar UD; Bresee JS; Gentsch JR; Glass RI
Emerg Infect Dis; 1998; 4(4):561-70. PubMed ID: 9866732
[TBL] [Abstract][Full Text] [Related]
37. Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group.
Ward RL; Knowlton DR; Zito ET; Davidson BL; Rappaport R; Mack ME
J Infect Dis; 1997 Sep; 176(3):570-7. PubMed ID: 9291301
[TBL] [Abstract][Full Text] [Related]
38. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants.
Araujo EC; Clemens SA; Oliveira CS; Justino MC; Rubio P; Gabbay YB; da Silva VB; Mascarenhas JD; Noronha VL; Clemens R; Gusmão RH; Sanchez N; Monteiro TA; Linhares AC
J Pediatr (Rio J); 2007; 83(3):217-24. PubMed ID: 17380232
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants.
Dhingra MS; Kundu R; Gupta M; Kanungo S; Ganguly N; Singh MP; Bhattacharya MK; Ghosh R; Kumar R; Sur D; Chadha SM; Saluja T
Vaccine; 2014 Aug; 32 Suppl 1():A117-23. PubMed ID: 25091664
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children.
Grant LR; Watt JP; Weatherholtz RC; Moulton LH; Reid R; Santosham M; O'Brien KL
Pediatr Infect Dis J; 2012 Feb; 31(2):184-8. PubMed ID: 22252206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
